Cancer BiologybioRxivPreprint
BIRC3: A Prognostic Predictor and Novel Therapeutic Target in TMZ-Resistant Glioblastoma Tumors
M. Morelli, S. Franceschi, F. Lessi…·C. M. Mazzanti
This study identifies BIRC3 as a prognostic biomarker and therapeutic target for TMZ-resistant glioblastoma, validated across multiple datasets and showing efficacy when combined with AZD5582.
DOI 10.1101/2023.08.23.554432